跳至主要内容
临床试验/CTRI/2026/02/104000
CTRI/2026/02/104000尚未招募不适用

Clinical profile of leprosy patient with neurological involvement and evaluation of cranial neuropathy using Advanced MRI sequences - A tertiary care centre based cross-sectional, observational study

Sushma Sharma1 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2026年3月3日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
103
试验地点
1

研究概览

简要总结

Leprosy is a chronic infection caused by Mycobacterium leprae, primarily affecting the skin and peripheral nerves. Neurological involvement is the most disabling aspect, resulting from Schwann cell invasion leading to inflammation, demyelination, and axonal loss, causing sensory, motor, and autonomic dysfunction with deformities. Emerging evidence challenges the traditional view that leprosy affects only peripheral nerves, showing involvement of the central and autonomic nervous systems. MRI studies have identified CNS lesions, particularly in brainstem regions associated with cranial nerve deficits.There is existing knowlege gap regarding the  full specturum of neurological involvement in  leprosy. The present study seek to analyse the neurological manifestation of leprosy through clinical evaluation and MRI findings in patients of leprosy with cranial neuropathy.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.All clinically confirmed cases of leprosy (as per WHO or Ridley–Jopling classification) including release from treatment.
  • 2.Patients presenting with neurological symptoms or signs such as: Cranial nerve palsies, Peripheral neuropathy (sensory, motor, or mixed) and autonomic dysfunction.
  • 3.Patients willing to participate and provide written informed consent.

排除标准

  • 1.Age less than 18 years, and more than 60 years 2.Pregnant and lactating female 3.Patients with neuropathies attributable to other etiologies according to clinical experts (e.g., diabetes mellitus, alcoholism, nutritional deficiency, heavy metal toxicity, vasculitis).
  • 4.Patients with contraindications to MRI (e.g., pacemaker, metallic implants, severe claustrophobia, high creatinine (1.2mg/dl).
  • 5.Patients unwilling to participate.

研究者

发起方
Sushma Sharma
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Sushma Sharma

All India Institute of Medical Science Gorakhpur

研究点 (1)

Loading locations...

相似试验